SEC Comment Letter for WINDTREE THERAPEUTICS (WINT) — Nov 15, 2010

WINDTREE THERAPEUTICS INC /DE/ (WINT, WINTW) (CIK 0000946486)
Date: Nov. 15, 2010 · CIK: 0000946486 · Accession: 0000000000-10-068028

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-26422

Date

November 15, 2010

Author

Gus Rodriguez

Form

UPLOAD

Company

WINDTREE THERAPEUTICS INC /DE/ (WINT, WINTW) (CIK 0000946486)

Letter

November 15, 2010 Mr. John G. Cooper Executive Vice President and Chief Financial Officer Discovery Laboratories, Inc. 2600 Kelly Road, Suite 100 Warrington, Pennsylvania 18976 Re: Discovery Laboratories, Inc . Form 10-K for the Year Ended December 31, 2009 Form 10-K/A for the Year Ended December 31, 2009 Forms 10-Q for the Quarterly Period s Ended March 31 and June 30, 2010 File No. 000-26422

Dear Mr. Cooper:

We have completed our review of your fili ngs and do not have any further comments at this time. Sincerely,

G u s R o d r i g u e z Accounting Branch Chief

Show Raw Text

November 15, 2010
 Mr. John G. Cooper Executive Vice President and Chief Financial Officer
Discovery Laboratories, Inc. 2600 Kelly Road, Suite 100    Warrington, Pennsylvania 18976
 Re: Discovery Laboratories, Inc .
  Form 10-K for the Year Ended December 31, 2009
Form 10-K/A for the Year Ended December 31, 2009
Forms 10-Q for the Quarterly Period s Ended March 31 and June 30, 2010
 File No. 000-26422

Dear Mr. Cooper:

We have completed our review of your fili ngs and do not have any further comments at
this time.
Sincerely,

        G u s  R o d r i g u e z
Accounting Branch Chief

SecProbe.io